Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside. 

In this episode:

Gary Gensler, @GaryGensler

Albert Bourla, @AlbertBourla

Meg Tirrell, @megtirrell

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Cameron Costa, @CameronCostaNY

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.